Rothschild Capital Partners LLC Purchases New Holdings in UnitedHealth Group Incorporated $UNH

Rothschild Capital Partners LLC bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 2,400 shares of the healthcare conglomerate’s stock, valued at approximately $998,000.

A number of other large investors have also added to or reduced their stakes in the stock. Senator Investment Group LP boosted its stake in UnitedHealth Group by 433.4% in the 2nd quarter. Senator Investment Group LP now owns 186,677 shares of the healthcare conglomerate’s stock worth $77,589,000 after purchasing an additional 151,677 shares in the last quarter. Moore Capital Management LP purchased a new position in UnitedHealth Group in the second quarter worth about $2,078,000. Benjamin Edwards Inc. grew its holdings in shares of UnitedHealth Group by 17.2% during the second quarter. Benjamin Edwards Inc. now owns 77,966 shares of the healthcare conglomerate’s stock valued at $32,417,000 after buying an additional 11,455 shares during the last quarter. Cookson Peirce & Co. Inc. purchased a new position in UnitedHealth Group in the 2nd quarter worth approximately $297,000. Finally, Northwestern Mutual Wealth Management Co. lifted its position in UnitedHealth Group by 4.1% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 272,738 shares of the healthcare conglomerate’s stock valued at $113,358,000 after acquiring an additional 10,790 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $393.99 on Monday. UnitedHealth Group Incorporated has a 12-month low of $255.96 and a 12-month high of $461.62. The firm has a market capitalization of $353.64 billion, a price-to-earnings ratio of 25.35, a price-to-earnings-growth ratio of 1.36 and a beta of 0.62. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The firm has a 50 day moving average of $413.28 and a 200 day moving average of $360.71.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, topping the consensus estimate of $4.94 by $1.44. The business had revenue of $112.03 billion for the quarter, compared to analysts’ expectations of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The company’s revenue was up .4% compared to the same quarter last year. During the same quarter last year, the company posted $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 19.82 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 22nd. Investors of record on Monday, September 14th will be paid a dividend of $2.32 per share. The ex-dividend date is Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.4%. UnitedHealth Group’s payout ratio is 59.72%.

Analysts Set New Price Targets

UNH has been the subject of several recent analyst reports. TD Cowen boosted their price target on UnitedHealth Group from $337.00 to $430.00 and gave the stock a “hold” rating in a research note on Tuesday, July 14th. Truist Financial boosted their target price on UnitedHealth Group from $440.00 to $480.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. KeyCorp raised their price target on shares of UnitedHealth Group from $400.00 to $475.00 and gave the company an “overweight” rating in a report on Tuesday, July 14th. HC Wainwright set a $492.00 price objective on shares of UnitedHealth Group in a report on Wednesday, May 27th. Finally, Royal Bank Of Canada raised their target price on shares of UnitedHealth Group from $463.00 to $478.00 and gave the stock an “outperform” rating in a report on Friday, July 17th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $456.56.

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 1,169 shares of the company’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the transaction, the chief executive officer owned 15,328 shares of the company’s stock, valued at $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.19% of the stock is owned by insiders.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.